Hospital departments, distributors, and researchers enter from academic meetings and website in parallel; the same hospital is filed twice; academic spend cannot map to people.
01 Industry judgment
Access and channels · Life sciences
Life-science deals are hospital plus product: department, distributor, and clinical nodes must be auditable and handoff-ready
Doctors own product preference, pharmacy owns price, distributors report progress. If the three cannot land on one hospital file, hospital access and clinical nodes lose dates. If academic events and visits live only in personal notes, coverage gaps cannot be judged after regional manager changes.
Reagents, consumables, instruments, and device sales that manage hospital endpoints and distributor channels with visit and material audit trails. This solution does not run registration filings.
Life sciences · How the business hangs together
Into leads
- Academic meeting form
- Product inquiry
- Distributor filing
Customer ledger
- Hospital / department
- Products in push
- Doctor / pharmacy / distributor
Follow-up actions
- Visit records
- Material email
- Clinical / access nodes
Manager board
- Duplicate files
- Node overdue
- Complaint unanswered
02 Process diagnosis
After the hospital–product judgment, split life-science deals into six process checks. Dedupe hospital and product before leads; hospital access, clinical, and volume procurement each have node dates; visits and academic events write to the hospital file; complaints and material versions reconcile from the customer record. Compliance needs an audit trail — instant messaging cannot satisfy audit.
Hospital access, clinical, and volume procurement cycles are long. Doctors, pharmacy, and distributors lack next dates; three months later they are still marked active follow-up.
Hard to convert
Academic events and visits live in personal notebooks. After regional manager changes, department relationships cannot hand off.
Hard to manage
Material promises and adverse-event communication cannot be traced — later access in that territory suffers.
Hard to trust
Monthly meetings only report shipments. Hospitals stuck in clinical and distributor coverage gaps cannot drive resource spend.
Hard to decide
Access experience and an audit-trail system must coexist. More medical support alone or a system alone cannot meet compliance logging.
Hard to solve
03 Matching management actions
01 · Hard to acquire
Dedupe hospital and product before assigning owners
Forms capture department, indication, and competitors in use. Academic and website sources listed apart; one hospital does not get a second file.
02 · Hard to convert
Write hospital access, clinical, and volume procurement as node dates
Doctor, pharmacy, and distributor listed apart. Materials email named people. Missing node dates are not valid follow-up.
03 · Hard to manage
Write visits and academic events to the hospital file
Regional manager changes only adjust the owner. Visit targets and sponsorship records stay on the customer.
04 · Hard to trust
Reconcile complaints and materials from the customer file
Inbound via call center attaches hospital and product. Promised reply dates due enter the list.
05 · Hard to decide
Staff academic spend from clinical stalls and coverage gaps
Hospitals stuck in clinical, blank distributors, and overdue revisits listed apart — replace single shipment counts.
06 · Hard to solve
Audit trail before feature expansion
Visits, email, and calls write back to the hospital first. Enable outbound once silent-hospital screening demand is clear. Registration filings are not done here.
Business architecture
Life science and devices as hospital plus product. Department, distributor, clinical nodes, and visit trails sit on one hospital file.
Into leads
Academic meeting form
Product inquiry
Distributor filing
Customer ledger
Hospital / department
Products in push
Doctor / pharmacy / distributor
Follow-up actions
Visit records
Material email
Clinical / access nodes
Manager board
Duplicate files
Node overdue
Complaint unanswered
Product role on this path
solutions.capabilitiesLead
Three questions before go-live
Sales will not fill forms, it fights the current stack, data will not migrate — almost every team asks these three.
Can academic visits stay only in the rep’s notebook?
No. Sample specs, material versions, and feedback dates must sit on the customer. After the rep changes, the lab is still there.
How do we file labs reported by distributors?
File the endpoint separately and note the source distributor. Do not treat order phones as lab leads.
Can compliance allow blasting product efficacy?
Materials go by email to that customer with versions kept. SMS only confirms agreed nodes — not efficacy claims.